GENOME ARCH
Programmable multicellular organisms engineered for environmental remediation, carbon capture, and the creation of living materials that heal our planet.
$420M
TOTAL RAISED
$3.2B
VALUATION
2019
FOUNDED
Series D
STAGE
THE VISION
Genome Arch is pioneering the field of programmable biology—engineering multicellular organisms that can sequester carbon 100x faster than trees, break down ocean plastics, and create self-healing building materials.
Their proprietary Bio-OS platform enables the design and simulation of complex biological systems before wet-lab synthesis. With deployments across 12 countries and partnerships with major oil companies for carbon offset programs, Genome Arch is leading the biological revolution.
"Nature is the original programmer. We're just learning to speak its language. Aether gave us the runway to think in decades, not quarters."
Dr. Yuki Tanaka
Co-Founder & Chief Science Officer, Genome Arch
KEY MILESTONES
Company Founded
Seed funding from Aether Ventures
Bio-OS Launch
Proprietary biological programming platform released
Global Deployment
Carbon capture organisms deployed in 12 countries
$1B Revenue Run Rate
First synthetic biology company to reach this milestone
Building Something Frontier?
We partner with founders who are architecting the impossible.
PITCH US YOUR VISION